Showing results (1841-1850 of 10,079) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|February 9, 2021
Irisin and Vascular Inflammation: Beneficial Effects of a Healthy Lifestyle Beyond Physical ActivityRoberto Restuccia, Fulvio Perani, Giovanni Ficarra, et al.Current Pharmaceutical Design|February 11, 2021
Thoracic Aortic Aneurysm: Blood Pressure and Inflammation as Key Factors in the Development of Aneurysm DissectionAnton Postnov, Andrey Suslov, Igor Sobenin, et al.Current Pharmaceutical Design|October 28, 2016
Study in Treatment of Collagen-Induced Arthritis in DBA/1 Mice Model by GenisteinYiping Hu, Jinchao Li, Ling Qin, et al.Current Pharmaceutical Design|October 28, 2016
The Roles of Endoplasmic Reticulum Stress in the Pathophysiological Development of Cartilage and ChondrocytesXiaoliang Yuan, Haiqing Liu, Linfu Li, et al.Current Pharmaceutical Design|October 28, 2016
Membrane-Based Technologies in the Pharmaceutical Industry and Continuous Production of Polymer-Coated Crystals/ParticlesDengyue Chen, Kamalesh K Sirkar, Chi Jin, et al.Current Pharmaceutical Design|October 28, 2016
Transferrin-Conjugated Nanocarriers as Active-Targeted Drug Delivery Platforms for Cancer TherapyDaniele R Nogueira-Librelotto, Cristiane F Codevilla, Ammad Farooqi, et al.Current Pharmaceutical Design|October 28, 2016
Current Trends in Drug Sensitivity PredictionIsidro Cortes-Ciriano, Lewis H Mervin, Andreas BenderCurrent Pharmaceutical Design|October 28, 2016
Mesoporous Silica Molecular Sieve based Nanocarriers: Transpiring Drug Dissolution ResearchSatyanarayan Pattnaik, Kamla PathakCurrent Pharmaceutical Design|December 6, 2016
Antiplatelet Agents and Anticoagulants in Patients with Chronic Kidney Disease - from Pathophysiology to Clinical PracticeJens Lutz, Kerstin JurkCurrent Pharmaceutical Design|December 6, 2016
Reversal Agents for Oral Antiplatelet and Anticoagulant Treatment During Bleeding Events: Current StrategiesPeter Raimondi, Elaine M Hylek, Konstantinos N AronisPageof 1,008